Redcare Pharmacy shares plunge as 2026 outlook disappoints

Redcare Pharmacy NV

04/03/2026 09:03

** Shares in Netherlands-based online pharmaceutical retailer Redcare Pharmacy RDC.DE fall 15% to their lowest level in over three years

** The company's 2026 outlook failed to meet analysts' expectations, a local trader says

** Redcare projects revenue growth of 13%-15%, well below an estimated 17% growth, according to the trader

** Its 2026 adjusted EBITDA margin is expected to reach at least 2.5%, while analysts polled by LSEG had predicted 3%

** 2025 adjusted EBITDA also fails to meet expectations at 57 million euros ($66 million) of the compared to company-compiled consensus of 64.5 million euros

($1 = 0.8621 euros)

(Reporting by Bernadette Hogg)

((bernadette.hogg@thomsonreuters.com))